As per notification in the Pharmaceutical Schedule Update September 2018 the incumbent product has been discontinued by the supplier and will be delisted from the Pharmaceutical Schedule and HML 1 April 2019.

PHARMAC stated at the time they were looking for an alternative supply and have advised today of a new listing effective 1 January 2019

INCUMBENT (delisting 1 April 2019)

Ferrum H Inj 50 mg / ml 2ml 5               Pharmacode 209082                        Schedule price $15.22

NEW (listing 1 January 2019)

Ferrosig Inj 50 mg / ml 2 ml 5                Pharmacode 2135914                   Schedule price $34.50

Reference pricing will not apply.

As of the date of this notification ProPharma / PWR cannot accept Ferrum H for credit under any circumstances.

Please continue to order the INCUMBENT and ProPharma / PWR will automatically replace as existing stocks are depleted.

This way we can ensure all product moves through the supply chain with no losses incurred by either party.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author